https://www.targetedonc.com/view/promising-efficacy-seen-with-lintuzumab-ac225-chemotherapy-in-r-r-aml
0
0
12/10/22 at 8:47pm
Organization
Targetedonc.com
Author
Dylann Cohn-Emery
36 words
0
Comments
Salvage chemotherapy after lintuzumab-Ac225 showed promising early efficacy results in patients with relapsed/refractory acute myeloid leukemia by eliminating residual leukemia cells.
You are the first to view
Create an account
or login to join the discussion